当前位置：首页 > 文献互助 > 互助详情

期刊论文Efficacy and safety of SHR-1701 combined with chemoradiotherapy as neoadjuvant treatment for locally advanced rectal cancer复制

用户QRAHz7LcpZFU 1个月前 84 已完结

1. 系统已在2026-02-16 12:12:04对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1016/j.canlet.2025.218006复制

文献链接:复制

其他信息:

上一篇：Immunotherapy of cholangiocarcinoma: Therapeutic strategies and predictive biomarkers

下一篇：IPO9 Promotes Ovarian Cancer Progression by Suppressing HMOX1‐Dependent Ferroptosis

互助时间线

2026-02-13 20:21:30 [完结求助]

系统完结了求助, 已自动确认了jodie0105应助的文件是正确的, 求助状态变成已完结

2026-02-09 12:12:04 [上传文件]

jodie0105上传了文件(pdf 737.54 KB), 求助状态变成待确认

2026-02-08 20:24:15 [驳回应助]

楼主驳回了小小探险家应助的文件, 求助状态回到求助中

备注: 这是乱码了吧

2026-02-08 20:21:35 [上传文件]

小小探险家上传了文件(pdf 878.37 KB), 求助状态变成待确认

2026-02-08 20:21:30 [发起求助]

最新发布的求助

Cost-Effectiveness Analysis of Anlotinib Plus Penpulimab Versus Sorafenib in the First-Line Treatment of Unresectable Hepatocellular Carcinoma in China 5分钟前

Reduction of Aldehydes with Formic acid in Ethanol using Immobilized Iridium Nanoparticles on a Triazine‐phosphanimine Polymeric Organic Support 9分钟前

Mechanical signaling via β2 integrin decouples T cell proliferation and differentiation for generating stem cell-like CAR T cells 10分钟前

Cost-effectiveness of first-line immune checkpoint inhibitor therapies, alone or combined with targeted agents, for unresectable hepatocellular carcinoma in China: an economic evaluation using network meta-analysis 10分钟前

Cost-Effectiveness Analysis of Anlotinib Plus Penpulimab Versus Sorafenib in the First-Line Treatment of Unresectable Hepatocellular Carcinoma in China 10分钟前

Anlotinib and penpulimab in advanced hepatocellular carcinoma: a new contender emerges 12分钟前

Biaxially strained PtPb/Pt core/shell nanoplate boosts oxygen reduction catalysis 16分钟前

Dual-core drive hydrogen transfer heterogeneous catalysts based on iridium-enzyme co-modified carbon nanotubes for aromatic aldehyde hydrogenation 35分钟前

… HIV Prevention and Antiretroviral Therapy from the Conference on Retroviruses and Opportunistic Infections (CROI) 2025 and Expectations from CROI 2026 38分钟前

Kinetics of the acid-catalyzed closure of hydantoic acids. Effect of 2-aryl and 2-alkyl substituents 1小时前

Molnupiravir is not a Selective CES2 Probe Substrate: In Vitro Evidence for CES1 Involvement 1小时前

Patent landscape and therapeutic evolution of Mazdutide: a dual GLP-1/Glucagon receptor agonist for obesity and type 2 diabetes 2小时前